DE602006020057D1 - A1-adenosinrezeptoragonisten - Google Patents
A1-adenosinrezeptoragonistenInfo
- Publication number
- DE602006020057D1 DE602006020057D1 DE602006020057T DE602006020057T DE602006020057D1 DE 602006020057 D1 DE602006020057 D1 DE 602006020057D1 DE 602006020057 T DE602006020057 T DE 602006020057T DE 602006020057 T DE602006020057 T DE 602006020057T DE 602006020057 D1 DE602006020057 D1 DE 602006020057D1
- Authority
- DE
- Germany
- Prior art keywords
- adenosine receptor
- receptor agonist
- angina
- release
- useful
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 101150007969 ADORA1 gene Proteins 0.000 title abstract 2
- 239000003379 purinergic P1 receptor agonist Substances 0.000 title abstract 2
- 229940122614 Adenosine receptor agonist Drugs 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010002383 Angina Pectoris Diseases 0.000 abstract 1
- 206010003662 Atrial flutter Diseases 0.000 abstract 1
- 208000001871 Tachycardia Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000021588 free fatty acids Nutrition 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 150000005830 nonesterified fatty acids Chemical class 0.000 abstract 1
- 230000006794 tachycardia Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US72661605P | 2005-10-13 | 2005-10-13 | |
| PCT/US2006/039975 WO2007047401A2 (en) | 2005-10-13 | 2006-10-11 | A1 adenosine receptor agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006020057D1 true DE602006020057D1 (de) | 2011-03-24 |
Family
ID=37865975
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006020057T Active DE602006020057D1 (de) | 2005-10-13 | 2006-10-11 | A1-adenosinrezeptoragonisten |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7488720B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1943251B8 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009511593A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE497960T1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2625783A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE602006020057D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2358351T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007047401A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7488720B2 (en) * | 2005-10-13 | 2009-02-10 | Cv Therapeutics, Inc. | A1 adenosine receptor agonists |
| CN101712709A (zh) * | 2008-10-06 | 2010-05-26 | 中国医学科学院药物研究所 | 三乙酰基-3-羟基苯基腺苷及其调血脂的用途 |
| CN120647702A (zh) | 2017-05-19 | 2025-09-16 | 全技术公司 | 药剂、组合物及其相关方法 |
| EP4541803A4 (en) * | 2022-06-17 | 2025-10-01 | Shanghai Senhui Medicine Co Ltd | CYCLOPENTYLADENOSINE DERIVATIVE AND ITS PHARMACEUTICAL USE |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| ES2264826T3 (es) * | 1998-10-16 | 2007-01-16 | Pfizer Inc. | Derivados de adenina. |
| US20030013675A1 (en) * | 2001-05-25 | 2003-01-16 | Boehringer Ingelheim Pharma Kg | Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases |
| US20030078232A1 (en) | 2001-08-08 | 2003-04-24 | Elfatih Elzein | Adenosine receptor A3 agonists |
| WO2004069185A2 (en) * | 2003-02-03 | 2004-08-19 | Cv Therapeutics Inc. | Partial and full agonists of a1 adenosine receptors |
| US7488720B2 (en) * | 2005-10-13 | 2009-02-10 | Cv Therapeutics, Inc. | A1 adenosine receptor agonists |
-
2006
- 2006-10-11 US US11/546,658 patent/US7488720B2/en not_active Expired - Fee Related
- 2006-10-11 WO PCT/US2006/039975 patent/WO2007047401A2/en not_active Ceased
- 2006-10-11 ES ES06825861T patent/ES2358351T3/es active Active
- 2006-10-11 DE DE602006020057T patent/DE602006020057D1/de active Active
- 2006-10-11 JP JP2008535686A patent/JP2009511593A/ja active Pending
- 2006-10-11 EP EP06825861A patent/EP1943251B8/en active Active
- 2006-10-11 AT AT06825861T patent/ATE497960T1/de active
- 2006-10-11 CA CA002625783A patent/CA2625783A1/en not_active Abandoned
-
2009
- 2009-02-03 US US12/365,072 patent/US20090137520A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1943251A2 (en) | 2008-07-16 |
| WO2007047401A3 (en) | 2007-06-14 |
| ATE497960T1 (de) | 2011-02-15 |
| ES2358351T8 (es) | 2011-06-15 |
| JP2009511593A (ja) | 2009-03-19 |
| WO2007047401A2 (en) | 2007-04-26 |
| CA2625783A1 (en) | 2007-04-26 |
| US20090137520A1 (en) | 2009-05-28 |
| US20070087994A1 (en) | 2007-04-19 |
| US7488720B2 (en) | 2009-02-10 |
| EP1943251B8 (en) | 2011-03-23 |
| ES2358351T3 (es) | 2011-05-09 |
| EP1943251B1 (en) | 2011-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2011000978A1 (es) | Compuestos derivados de fenil-amida o piridil-amida, agonistas de gpbar1; proceso de preparacion; composicion farmaceutica; y su uso en diabetes, isquemia, obesidad, dislipidemia, entre otras. | |
| MY180473A (en) | Imaging and evaluating embryos, oocytes, and stem cells | |
| CL2009001476A1 (es) | Compuestos derivados de 2,4-diamin-n2-fenil pirimidina sustituidos, mediadores de la inhibicion de igf-1r; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades autoinmune, por trasplante, infecciosas o un trastorno proliferativo celular. | |
| Ligasová et al. | A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity | |
| EA200800100A1 (ru) | Соединения азаиндазола и способы применения | |
| EA200800727A1 (ru) | Введение ингибиторов дипептидилпептидазы | |
| ECSP11010798A (es) | 1,2,5-oxadiazoles como inhibidores de indolamina 2,3-dioxigenasa | |
| EA200800726A1 (ru) | Введение ингибиторов дипептидилпептидазы | |
| BRPI0911273A2 (pt) | inibidor de dpp-iv combinado com outro agente antidiabético, comprimidos que compreendem tais formulações, seu uso e processo para sua preparação | |
| ES2337973B8 (es) | Adenovirus auxiliares auto-inactivantes para la produccion de adenovirus recombinantes de alta capacidad. | |
| Fu et al. | Direct repair of 3, N4-ethenocytosine by the human ALKBH2 dioxygenase is blocked by the AAG/MPG glycosylase | |
| EA201071221A1 (ru) | Гетероциклические соединения | |
| ATE497960T1 (de) | A1-adenosinrezeptoragonisten | |
| EA200701600A1 (ru) | Способ получения лёгкодоступного клеточного материала из периферической крови и композиция на его основе | |
| PE20060558A1 (es) | Conjugados para el diagnostico de enfermedades asociadas con angiogenesis que comprenden un ligante especifico para angiogenesis y una tintura de cianina | |
| TW200616649A (en) | Partial and full agonists of A1 adenosine receptors | |
| EA200701592A1 (ru) | Композиты и способы их получения и использования | |
| ECSP077845A (es) | Composiciones y sales dermatológicas para el tratamiento de enfermedades dermatológicas | |
| Lan et al. | Rho-kinase mediated cytoskeletal stiffness in skinned smooth muscle | |
| WO2008058238A3 (en) | Adenosine a1 and a3 receptor gene sequence variations for predicting disease outcome and treatment outcome | |
| ATE474834T1 (de) | Als agonisten des gpr38-rezeptors geeignete biarylverbindungen | |
| BRPI0717448A2 (pt) | Composição detergente sólida para lavagem de roupas altamente solúvel em água, de baixa densidade e baixo builder | |
| TW200621793A (en) | Partial and full agonists of a1 adenosine receptors | |
| CL2013001601A1 (es) | Proceso para licuar una o mas proteinas de cereal, que comprende las etapas de : a) suministrar una composicion que comprende una o mas de proteinas de cereal de un 5-40% en peso de materia seca; b) añadir una o mas enzimas hidroliticas y/o auxiliares de procesamiento; c) opcionalmente, preacondicionar; d) homogeneizar; ademas opcionalmente pretratar la composicion obtenida, e incubar la composicion a una temperatura de 50-85 grados celsius durante al menos 5 minutos. | |
| WO2006116197A3 (en) | Methods of identifying individuals at risk of perioperative myocardial injury, major adverse cardiac events, cognitive decline, arrhythmias, depression or bleeding |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: GILEAD PALO ALTO, INC., FOSTER CITY, CALIF., US |